Cardura XL (doxazosin) extended release tablets 8 mg, 30-count bottle, Rx only, Distributed by Vi...

FDA Recall #D-0203-2025 — Class II — December 23, 2024

Recall #D-0203-2025 Date: December 23, 2024 Classification: Class II Status: Terminated

Product Description

Cardura XL (doxazosin) extended release tablets 8 mg, 30-count bottle, Rx only, Distributed by Viatris Specialty LLC, Morgantown, WV 26505, NDC 58151-079-93

Reason for Recall

Failed Impurities/Degradation Specifications: Out of specification results observed for the impurity compound B during stability testing.

Recalling Firm

Viatris Inc — Canonsburg, PA

Classification

Class II — May cause temporary or medically reversible adverse health consequences.

Product Type

Drugs

Product Quantity

1,215/30 count bottles

Distribution

USA nationwide.

Code Information

Lot # 8181625, Exp 12/31/2025

Status

Terminated

Voluntary / Mandated

Voluntary: Firm initiated